These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16710946)

  • 1. Update on influenza vaccination for the 2005-2006 season. An Advisory Committee Statement (ACS).
    Advisory Committee On Immunization (NACI)
    Can Commun Dis Rep; 2006 Mar; 32(ACS-2):1-3. PubMed ID: 16710946
    [No Abstract]   [Full Text] [Related]  

  • 2. Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 Jun; 32(ACS-7):1-27. PubMed ID: 16805064
    [No Abstract]   [Full Text] [Related]  

  • 3. Statement on influenza vaccination for the 2005-2006 season. An advisory committee statement.
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2005 Jun; 31(ACS-6):1-30. PubMed ID: 15959943
    [No Abstract]   [Full Text] [Related]  

  • 4. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Jul; 33(ACS-7):1-38. PubMed ID: 17663034
    [No Abstract]   [Full Text] [Related]  

  • 5. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2008 Jul; 34(ACS-3):1-46. PubMed ID: 18802991
    [No Abstract]   [Full Text] [Related]  

  • 6. ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices.
    Preboth M;
    Am Fam Physician; 2001 Oct; 64(7):1270, 1272-5. PubMed ID: 11601808
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HHS-CDC NEWS: update: influenza activity--US and worldwide, 2005-2006 season, and composition of the 2006-2007 influenza vaccine.
    Ann Pharmacother; 2006; 40(7-8):1499-500. PubMed ID: 16849615
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
    Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statement on influenza vaccination for the 1995-96 season. National Advisory Committee on Immunization.
    CMAJ; 1995 Sep; 153(5):591-604. PubMed ID: 7641158
    [No Abstract]   [Full Text] [Related]  

  • 11. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jan; 55(2):44-6. PubMed ID: 16424859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oseltamivir resistant influenza in children].
    Schlegel A
    Med Monatsschr Pharm; 2005 Oct; 28(10):363-4. PubMed ID: 16245454
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(50):308. PubMed ID: 16503051
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
    Schmidtke M; Bauer K; Ludwig N; Wutzler P
    Int J Antimicrob Agents; 2008 Aug; 32(2):192-5. PubMed ID: 18571381
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza surveillance with rapid diagnostic tests.
    Uyeki TM; Fukuda K; Cox NJ
    Clin Infect Dis; 2002 May; 34(10):1422. PubMed ID: 11981745
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan.
    Iwahashi J; Tsuji K; Ishibashi T; Kajiwara J; Imamura Y; Mori R; Hara K; Kashiwagi T; Ohtsu Y; Hamada N; Maeda H; Toyoda M; Toyoda T
    J Clin Microbiol; 2001 Apr; 39(4):1652-3. PubMed ID: 11283109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza in Canada: 2005-2006 season.
    Reyes F; Macey JF; Aziz S; Li Y; Watkins K; Winchester B; Zabchuck P; Zheng H; Huston P; Tam TW; Hatchette T
    Can Commun Dis Rep; 2007 Feb; 33(3):21-41. PubMed ID: 17323533
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of antiviral resistance of influenza viruses.
    Monto AS
    Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.